In BRAF inhibitor-resistant melanoma cells, inhibition of actin polymerisation and actomyosin contractility was found to suppress both YAP/TAZ activity and drug-resistance, thus highlighting an important role of the actin cytoskeleton in this context [183]. The gene discussed is WWTR1; the disease is melanoma.